FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

[ad_1] A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March…

Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds

[ad_1] Patients who took Eli Lilly‘s weight loss drug tirzepatide lost up to 34 pounds on average, or 16% of their body weight, the company said in clinical trial results…